Liabilities / Assets
53rd percentile
Higher debt load relative to assets than 53% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
53rd percentile
Higher debt load relative to assets than 53% of similar nonprofits.
Liabilities / Revenue
47th percentile
Higher debt load relative to revenue than 47% of similar nonprofits.
Net Margin
60th percentile
Higher net margin than 60% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
60th percentile
Faster asset growth than 60% of similar nonprofits.
Revenue Growth
63rd percentile
Faster revenue growth than 63% of similar nonprofits.
Assets
Up$52,761,398
Up $2,741,553 (+5.5%) from 2011
Net Assets
Up$32,591,017
Up $3,019,715 (+10%) from 2011
Liabilities
Down$20,170,381
Down $278,162 (-1.4%) from 2011
Revenue
Up$45,631,731
Up $3,799,986 (+9.1%) from 2011
Expenses
Down$42,489,583
Down $71,694 (-0.2%) from 2011
Net Income
Up$3,142,148
Up $3,871,680 (+531%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The prostate cancer foundation (pcf) is a global biomedical research funding foundation committed to ending death and suffering from prostate cancer. Pcf accelerates the world's most promising prostate cancer research with the goal of discovering and developing new precision prevention, earlier detection and genomic medicines for prostate cancer.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.